Stonebridge Capital Advisors’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-27
Closed -$3.79K 930
2023
Q2
$3.79K Sell
27
-287
-91% -$42.2K ﹤0.01% 748
2023
Q1
$43.6K Buy
314
+26
+9% +$3.5K 0.01% 385
2022
Q4
$39K Buy
288
+121
+72% +$15.2K ﹤0.01% 388
2022
Q3
$18K Buy
167
+14
+9% +$1.78K ﹤0.01% 486
2022
Q2
$20K Sell
153
-68
-31% -$8.92K ﹤0.01% 489
2022
Q1
$29K Hold
221
﹤0.01% 472
2021
Q4
$26K Sell
221
-20
-8% -$2.35K ﹤0.01% 466
2021
Q3
$29K Sell
241
-144
-37% -$16.8K ﹤0.01% 423
2021
Q2
$42K Buy
385
+221
+135% +$24.2K ﹤0.01% 497
2021
Q1
$16K Buy
+164
New +$16.5K ﹤0.01% 540
2020
Q3
Sell
-181
Closed -$19K 224
2020
Q2
$19K Hold
181
﹤0.01% 404
2020
Q1
$16K Sell
181
-242
-57% -$22.8K ﹤0.01% 413
2019
Q4
$42K Buy
423
+227
+116% +$21.4K 0.01% 341
2019
Q3
$17K Hold
196
﹤0.01% 472
2019
Q2
$16K Buy
+196
New +$15.4K ﹤0.01% 495

Other funds holding AZN